Reported results
- Net income available to SiriusPoint common shareholders was $86.8 million, or $0.74 per diluted common share, for the third quarter of 2026
- Non-GAAP operating earnings per share was $0.88 for the third quarter of 2026
- GAAP combined ratio was 86.5% for the third quarter of 2026
- Non-GAAP Core combined ratio was 90.1% for the third quarter of 2026
- Non-GAAP Operating net income was $103.2 million for the third quarter of 2026
- Non-GAAP book value per diluted common share ex. AOCI was $20.21 as of September 30, 2026
Notes
In the fourth quarter of 2026, SiriusPoint plans to realign its reportable segments to Accident & Health and Specialty P&C. Additionally, the company entered into a loss portfolio transfer agreement with RiverStone covering substantially all remaining run-off reserves.
Price and volatility reaction
The stock moved +0.2% on the print. No front-expiry chain was on file, so there is no straddle expected move. 30-day ATM implied volatility moved -29.5 vol points across the event (constant-maturity series — not the front-week crush).
| Measure | Value | Basis |
|---|---|---|
| Close before release | 26.27 | 2026-11-05 |
| Close after release | 26.33 | 2026-11-06 |
| Realised move | +0.2% | close to close |
| 30d ATM IV change | -29.5 vol pts | constant-maturity series, not the front expiry |
Source
The figures above come from the earnings release the company filed with the SEC on 2026-11-05 (8-K, Item 2.02). Read the original filing on sec.gov.
